Back to Search Start Over

Evaluation of a Remote Monitoring System for Diabetes Control.

Authors :
Katalenich B
Shi L
Liu S
Shao H
McDuffie R
Carpio G
Thethi T
Fonseca V
Source :
Clinical therapeutics [Clin Ther] 2015 Jun 01; Vol. 37 (6), pp. 1216-25. Date of Electronic Publication: 2015 Apr 11.
Publication Year :
2015

Abstract

Purpose: The use of technology to implement cost-effective health care management on a large scale may be an alternative for diabetes management but needs to be evaluated in controlled trials. This study assessed the utility and cost-effectiveness of an automated Diabetes Remote Monitoring and Management System (DRMS) in glycemic control versus usual care.<br />Methods: In this randomized, controlled study, patients with uncontrolled diabetes on insulin were randomized to use of the DRMS or usual care. Participants in both groups were followed up for 6 months and had 3 clinic visits at 0, 3, and 6 months. The DRMS used text messages or phone calls to remind patients to test their blood glucose and to report results via an automated system, with no human interaction unless a patient had severely high or low blood glucose. The DRMS made adjustments to insulin dose(s) based on validated algorithms. Participants reported medication adherence through the Morisky Medication Adherence Scale-8, and diabetes-specific quality of life through the diabetes Daily Quality of Life questionnaire. A cost-effectiveness analysis was conducted based on the estimated overall costs of DRMS and usual care.<br />Findings: A total of 98 patients were enrolled (59 [60%] female; mean age, 59 years); 87 participants (89%) completed follow-up. HbA1c was similar between the DRMS and control groups at 3 months (7.60% vs 8.10%) and at 6 months (8.10% vs 7.90%). Changes from baseline to 6 months were not statistically significant for self-reported medication adherence and diabetes-specific quality of life, with the exception of the Daily Quality of Life-Social/Vocational Concerns subscale score (P = 0.04).<br />Implications: An automated system like the DRMS may improve glycemic control to the same degree as usual clinic care and may significantly improve the social/vocational aspects of quality of life. Cost-effectiveness analysis found DRMS to be cost-effective when compared to usual care and suggests DRMS has a good scale of economy for program scale up. Further research is needed to determine how to sustain the benefits seen with the automated system over longer periods.<br /> (Copyright © 2015 Elsevier HS Journals, Inc. All rights reserved.)

Details

Language :
English
ISSN :
1879-114X
Volume :
37
Issue :
6
Database :
MEDLINE
Journal :
Clinical therapeutics
Publication Type :
Academic Journal
Accession number :
25869625
Full Text :
https://doi.org/10.1016/j.clinthera.2015.03.022